English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

early experience with LT for HCC was disappointing, with 5-year survival rates of approximately 25%, outcomes have significantly improved over time, partially due to the application of stringent eligibility criteria when selecting patients for undergoing LT for HCC. Currently, patients undergoing LT for HCC have a 5-year survival rate exceeding 70%, which is similar to the survival seen in patients undergoing LT for other indications. [3] The observed tumor recurrence rates are less than 15% at 5 years. [3,5] It has therefore been suggested that LT is an effective option for patients with HCC corresponding to the Milan criteria, i.e., solitary tumor ,5 cm in size or up to three nodules ,3 cm in size.

Ancient schwannoma of the neck mimicking soft tissue sarcoma